HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interleukin 27 Protects From Gastric Atrophy and Metaplasia During Chronic Autoimmune Gastritis.

AbstractBACKGROUND & AIMS:
The association between chronic inflammation and gastric carcinogenesis is well established, but it is not clear how immune cells and cytokines regulate this process. We investigated the role of interleukin 27 (IL27) in the development of gastric atrophy, hyperplasia, and metaplasia (preneoplastic lesions associated with inflammation-induced gastric cancer) in mice with autoimmune gastritis.
METHODS:
We performed studies with TxA23 mice (control mice), which express a T-cell receptor against the H+/K+ adenosine triphosphatase α chain and develop autoimmune gastritis, and TxA23xEbi3-/- mice, which develop gastritis but do not express IL27. In some experiments, mice were given high-dose tamoxifen to induce parietal cell atrophy and spasmolytic polypeptide-expressing metaplasia (SPEM). Recombinant IL27 was administered to mice with mini osmotic pumps. Stomachs were collected and analyzed by histopathology and immunofluorescence; we used flow cytometry to measure IL27 and identify immune cells that secrete IL27 in the gastric mucosa. Single-cell RNA sequencing was performed on immune cells that infiltrated stomach tissues.
RESULTS:
We identified IL27-secreting macrophages and dendritic cell in the corpus of mice with chronic gastritis (TxA23 mice). Mice deficient in IL27 developed more severe gastritis, atrophy, and SPEM than control mice. Administration of recombinant IL27 significantly reduced the severity of inflammation, atrophy, and SPEM in mice with gastritis. Single-cell RNA sequencing showed that IL27 acted almost exclusively on stomach-infiltrating CD4+ T cells to suppress expression of inflammatory genes.
CONCLUSIONS:
In studies of mice with autoimmune gastritis, we found that IL27 is an inhibitor of gastritis and SPEM, suppressing CD4+ T-cell-mediated inflammation in the gastric mucosa.
AuthorsKevin A Bockerstett, Christine P Petersen, Christine N Noto, Lindsey M Kuehm, Chun Fung Wong, Eric L Ford, Ryan M Teague, Jason C Mills, James R Goldenring, Richard J DiPaolo
JournalCellular and molecular gastroenterology and hepatology (Cell Mol Gastroenterol Hepatol) Vol. 10 Issue 3 Pg. 561-579 ( 2020) ISSN: 2352-345X [Electronic] United States
PMID32376420 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
CopyrightCopyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Ebi3 protein, mouse
  • Il27 protein, mouse
  • Interleukins
  • Minor Histocompatibility Antigens
  • Receptors, Cytokine
  • Recombinant Proteins
Topics
  • Animals
  • Atrophy (immunology, pathology, prevention & control)
  • Autoimmune Diseases (diagnosis, drug therapy, immunology, pathology)
  • CD4-Positive T-Lymphocytes (drug effects, immunology, metabolism)
  • Chronic Disease (drug therapy)
  • Disease Models, Animal
  • Female
  • Gastric Mucosa (cytology, drug effects, immunology, pathology)
  • Gastritis (diagnosis, drug therapy, immunology, pathology)
  • Humans
  • Interleukins (administration & dosage)
  • Male
  • Metaplasia (immunology, pathology, prevention & control)
  • Mice
  • Mice, Knockout
  • Minor Histocompatibility Antigens (genetics)
  • Precancerous Conditions (immunology, pathology, prevention & control)
  • Receptors, Cytokine (genetics)
  • Recombinant Proteins (administration & dosage)
  • Severity of Illness Index

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: